Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children

1987 ◽  
Vol 146 (4) ◽  
pp. 404-407 ◽  
Author(s):  
J. Issakainen ◽  
B. F. D. Bourgeois
2004 ◽  
Vol 102 (1-3) ◽  
pp. 001-010 ◽  
Author(s):  
Ferah Armutcu ◽  
Elif Ozerol ◽  
Ahmet Gurel ◽  
Mehmet Kanter ◽  
Huseyin Vural ◽  
...  

2007 ◽  
Vol 30 (3) ◽  
pp. 145-149 ◽  
Author(s):  
Achilleas Attilakos ◽  
Konstantinos A. Voudris ◽  
Eustathia Katsarou ◽  
Alexia Prassouli ◽  
Sotiria Mastroyianni ◽  
...  

2006 ◽  
Vol 70 (2-3) ◽  
pp. 211-217 ◽  
Author(s):  
Konstantinos A. Voudris ◽  
Achilleas Attilakos ◽  
Eustathia Katsarou ◽  
Antonios Drakatos ◽  
Stamatia Dimou ◽  
...  

2008 ◽  
Vol 25 (3) ◽  
pp. 183-195
Author(s):  
Tanvir K. Gill ◽  
Ashish R. Agrawal ◽  
Muzaffar Iqbal ◽  
Tausif Monif ◽  
P.L. Sharma

1991 ◽  
Vol 20 (3) ◽  
pp. 237-244 ◽  
Author(s):  
Ronald Hartley ◽  
W. Ian Forsythe ◽  
Bruce McLain ◽  
Pak C. Ng ◽  
Mark D. Lucock

2009 ◽  
Vol 24 (1) ◽  
pp. 80-86 ◽  
Author(s):  
Murat Anil ◽  
Mehmet Helvaci ◽  
Ebru Ozbal ◽  
Onder Kalenderer ◽  
Ayse Berna Anil ◽  
...  

2021 ◽  
Vol 25 (1) ◽  
pp. 117-121
Author(s):  
Anum Shah ◽  
Imran Mahmood Khan ◽  
Sajid Hussain Sherazi ◽  
Taniah Ashfaq ◽  
Sajid Hussain Shah

Objective: To determine the association of long term sodium valproate monotherapy and vitamin D3 levels in epileptic children Methods: This cross-sectional study was conducted in the Department of Pediatrics, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad for six months from 15th February 2019 to 14th August 2019. A total of one hundred and thirty (n=130) children and adolescents of either gender between age 3-18 years who had a history of two seizures at least 24 hours apart in their life and were on sodium valproate monotherapy for more than one year were enrolled in this study through non-probability, consecutive sampling. Serum vitamin D3 (25-hydroxy vitamin D) levels were measured in all the patients at the time of enrolment into the study. All the demographic data and laboratory investigations were entered on the predesigned proforma and analyzed through SPSS version 17. Results: Vitamin D3 deficiency was found in 47 (36.2%) children which were significantly higher among patients with older age and longer duration of treatment (P<0.05) while gender and BMI of the patients did not show any significant difference (P>0.05). Conclusion: Significant percentage of epileptic children on sodium valproate monotherapy was found to have vitamin D3 deficiency. Therefore we recommend routine screening of vitamin D3 deficiency in all the epileptic children on long-term sodium valproate therapy followed by vitamin D supplementation in deficient patients.  


Sign in / Sign up

Export Citation Format

Share Document